Coenzyme Q10
Trials 63 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials | ||||||
| Phase 0 | NCT06361680 | Oct 2024 → Oct 2025 | type 1 diabetes mellitus | Assiut University | Unknown | No outcome recorded |
| Phase 0 | NCT06419335 | Jul 2024 → Apr 2026 overdue | Crohn disease | University of Pennsylvania | Active not recruiting | No outcome recorded |
| Phase 0 | NCT05945160 | Jan → Aug 2024 | vestibular disorder | The University of Texas Health Science Center at San Antonio | Withdrawn | No outcome recorded |
| Phase 0 | NCT03956017 | Aug 2013 → Aug 2022 | — | Minneapolis Veterans Affairs Medical Center | Unknown | No outcome recorded |
| Phase 0 | NCT00860743 | Sep 2009 → Sep 2013 | sleep apnea syndrome | VA Office of Research and Development | Completed | No outcome recorded |
| Phase 16 trials | ||||||
| Phase 1 | NCT06856447 | Jun 2024 → May 2025 overdue | colorectal cancer | toqa saad mohammed mohammed | Recruiting | No outcome recorded |
| Phase 1 | NCT03020602 | Jan 2017 → Apr 2019 | brain astrocytoma, gliosarcoma | Seema Nagpal | Completed | No outcome recorded |
| Phase 1 | NCT03002935 | Jan → Mar 2017 | — | BPGbio | Completed | No outcome recorded |
| Phase 1 | NCT02793960 | Aug 2016 → Aug 2019 | epidermolysis bullosa | Shasa Hu | Completed | No outcome recorded |
| Phase 1 | NCT00976131 | Sep 2009 → Sep 2012 | breast cancer | Columbia University | Completed | No outcome recorded |
| Phase 1 | NCT00117403 | Jan 2006 → Sep 2007 | Alzheimer disease | National Institute on Aging (NIA) | Completed | No outcome recorded |
| Phase 1/25 trials | ||||||
| Phase 1/2 | NCT07668284 | Jul 2026 → Feb 2030 expected | anus cancer, cervical cancer, prostate cancer | University of Nebraska | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT00652080 | Jun 2008 → Jan 2010 | squamous cell carcinoma | BPGbio | Completed | No outcome recorded |
| Phase 1/2 | NCT00604890 | Mar 2008 → Jan 2010 | basal cell carcinoma | BPGbio | Completed | No outcome recorded |
| Phase 1/2 | NCT00541164 | Sep 2007 → Jan 2013 | Charcot-Marie-Tooth disease | Memorial Medical Center | Completed | No outcome recorded |
| Phase 1/2 | NCT00247026 | Apr 2007 → ? | myelodysplastic syndrome | Hadassah Medical Organization | Withdrawn | No outcome recorded |
| Phase 218 trials | ||||||
| Phase 2 | NCT06555575 | Jan 2025 → Sep 2026 expected | — | Trio Fertility | Recruiting | No outcome recorded |
| Phase 2 | NCT06570811 | Aug 2024 → Mar 2025 | breast cancer, chemotherapy-induced toxicity | Damanhour University | Completed | No outcome recorded |
| Phase 2 | NCT07096557 | Jan → Nov 2024 | pediatric systemic lupus erythematosus | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT05984745 | Oct 2023 → Jul 2025 overdue | NAFLD1 | Ain Shams University | Recruiting | No outcome recorded |
| Phase 2 | NCT04752813 | Aug 2022 → Aug 2026 overdue | glioblastoma | BPGbio | Active not recruiting | No outcome recorded |
| Phase 2 | NCT05429229 | Nov 2021 → Dec 2023 | diabetic retinopathy, disorder of defective peroxisome oxidative status, dry eye syndrome | Adolfo Daniel Rodriguez-Carrizalez | Unknown | No outcome recorded |
| Phase 2 | NCT03111433 | Mar 2017 → Jan 2018 | type 1 diabetes mellitus | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT02650804 | Jul 2016 → Jun 2019 | malignant pancreatic neoplasm | BPGbio | Completed | No outcome recorded |
| Phase 2 | NCT01319110 | Feb → Dec 2011 | cardiac arrest, sudden cardiac arrest | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT02062034 | Feb 2011 → Nov 2013 | diabetic retinopathy, type 2 diabetes mellitus | University of Guadalajara | Completed | No outcome recorded |
| Phase 2 | NCT00920699 | Feb 2010 → Mar 2012 | Huntington disease | Johns Hopkins University | Completed | No outcome recorded |
| Phase 2 | NCT00605709 | Mar → Jul 2008 | skin squamous cell carcinoma | BPGbio | Withdrawn | No outcome recorded |
| Phase 2 | NCT00327756 | May 2006 → May 2009 | bipolar disorder, depressive disorder | National Institute of Mental Health (NIMH) | Withdrawn | No outcome recorded |
| Phase 2 | NCT00243932 | Apr 2005 → Mar 2008 | amyotrophic lateral sclerosis | Columbia University | Completed | No outcome recorded |
| Phase 2 | NCT00076492 | Jan 2004 → Sep 2005 | Parkinson disease | University of Rochester | Completed | No outcome recorded |
| Phase 2 | NCT00703482 | May 2003 → Sep 2004 | — | Solvay Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT00033189 | Sep 2001 → Jan 2005 | Duchenne muscular dystrophy | Cooperative International Neuromuscular Research Group | Completed | No outcome recorded |
| Phase 2 | NCT00004731 | Sep 1998 → Oct 2003 | Parkinson disease | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 2/33 trials | ||||||
| Phase 2/3 | NCT05871086 | May → Dec 2023 | juvenile idiopathic arthritis | Nourhan Elsherif | Unknown | No outcome recorded |
| Phase 2/3 | NCT05293132 | Feb 2022 → Jun 2023 | infectious disease with sepsis | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT00532571 | Jan 2004 → Sep 2005 | progressive supranuclear palsy | Lahey Clinic | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT06405204 | Jun → Dec 2024 | — | Beni-Suef University | Unknown | No outcome recorded |
| Phase 3 | NCT05731596 | Jun 2023 → Feb 2024 | metabolic dysfunction-associated steatohepatitis | Tanta University | Unknown | No outcome recorded |
| Phase 3 | NCT00740714 | Dec 2008 → Aug 2011 | Parkinson disease | Weill Medical College of Cornell University | Terminated | No outcome recorded |
| Phase 3 | NCT00180037 | Sep 2003 → Jun 2005 | Parkinson disease | Technical University Dresden | Completed | No outcome recorded |
| Phase 47 trials | ||||||
| Phase 4 | NCT06743802 | Jan 2025 → Mar 2026 overdue | — | The Second Affiliated Hospital of Chongqing Medical University | Recruiting | No outcome recorded |
| Phase 4 | NCT06452134 | Jul → Sep 2024 | alveolar periostitis, temporomandibular joint disorder | Zahra Nejati | Unknown | No outcome recorded |
| Phase 4 | NCT06429345 | Jun → Oct 2024 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 4 | NCT04302532 | Jul → Sep 2020 | — | Karachi Medical and Dental College | Completed | No outcome recorded |
| Phase 4 | NCT03104998 | Aug 2017 → Mar 2018 | infertility disorder | PharmEvo Pvt Ltd | Withdrawn | No outcome recorded |
| Phase 4 | NCT02115581 | Sep 2006 → Mar 2008 | dilated cardiomyopathy | University of Tehran | Completed | No outcome recorded |
| Phase 4 | NCT00307996 | Mar → Dec 2004 | chronic renal failure syndrome | University of Shizuoka | Completed | No outcome recorded |
| Phase not applicable15 trials | ||||||
| — | NCT07317440 | Dec 2025 → Jun 2026 overdue | — | Tanta University | Not yet recruiting | No outcome recorded |
| — | NCT07252518 | Oct 2025 → Jul 2026 overdue | male infertility | Mst.Sumyara Khatun | Recruiting | No outcome recorded |
| — | NCT06373848 | Mar → May 2024 overdue | chronic periodontitis | Islamic Azad University, Sanandaj | Enrolling by invitation | No outcome recorded |
| — | NCT06358963 | Feb → Apr 2024 | periodontal disorder | Amirhossein Farahmand | Unknown | No outcome recorded |
| — | NCT06661018 | Jan → Apr 2024 | ST-elevation myocardial infarction | Universitas Diponegoro | Completed | No outcome recorded |
| — | NCT05653895 | Dec 2022 → Dec 2023 | polycystic ovary syndrome | Khyber Medical University Peshawar | Completed | No outcome recorded |
| — | NCT06042738 | Mar → Nov 2021 | male infertility | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT04444349 | Feb 2021 → Dec 2025 overdue | cardiovascular disorder | Nanjing Medical University | Recruiting | No outcome recorded |
| — | NCT04487652 | Sep 2020 → Aug 2022 | gingival recession | University of Bern | Completed | No outcome recorded |
| — | NCT02218476 | Sep 2013 → Sep 2016 | — | Maimónides Biomedical Research Institute of Córdoba | Unknown | No outcome recorded |
| — | NCT01925937 | Jun 2013 → Jan 2014 | congestive heart failure | Isfahan University of Medical Sciences | Unknown | No outcome recorded |
| — | NCT01390389 | Jul 2011 → Jul 2012 | bipolar depression | Mclean Hospital | Completed | No outcome recorded |
| — | NCT01910766 | Jan 2010 → Jan 2013 | polycystic ovary syndrome | Mansoura University | Completed | No outcome recorded |
| — | NCT00716612 | Jan 2009 → Sep 2012 | statin toxicity | Hadassah Medical Organization | Completed | No outcome recorded |
| — | NCT00720369 | Jul 2008 → Mar 2010 | bipolar depression | Mclean Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 28 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT06089395 Comparator | Jun 2024 → Aug 2025 | ovarian dysfunction | Shi Yun | Unknown | No outcome recorded |
| Phase 0 | NCT04999488 Comparator | Dec 2023 → Dec 2024 | muscular atrophy | AdventHealth Translational Research Institute | Withdrawn | No outcome recorded |
| Phase 0 | NCT06342856 Comparator | Jun 2023 → Jun 2024 | oligospermia | Ain Shams University | Unknown | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT04091698 Comparator | Oct 2019 → Oct 2021 | lichen planus, oral | Cairo University | Unknown | No outcome recorded |
| Phase 1 | NCT02486055 Comparator | Nov 2015 → Jan 2016 | — | BPGbio | Completed | No outcome recorded |
| Phase 1 | NCT00957216 Comparator | Apr 2008 → Aug 2009 | sporadic adult-onset ataxia of unknown etiology | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02486796 Comparator | Feb 2016 → Mar 2017 | — | Midwestern Regional Medical Center | Terminated | No outcome recorded |
| Phase 26 trials | ||||||
| Phase 2 | NCT06962657 Comparator | May 2026 → Oct 2028 expected | — | University of California, San Diego | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06620523 Comparator | Jul 2024 → Jun 2027 expected | coronary artery disorder, kidney failure | George Washington University | Recruiting | No outcome recorded |
| Phase 2 | NCT05873673 Comparator | Jun 2023 → Mar 2025 overdue | odontogenic cyst | Fayoum University | Active not recruiting | No outcome recorded |
| Phase 2 | NCT04960215 Comparator | May 2021 → Feb 2022 | COVID-19, long COVID-19 | Aarhus University Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01471652 Comparator | Mar 2012 → Feb 2013 | myalgic encephalomeyelitis/chronic fatigue syndrome | Columbia University | Withdrawn | No outcome recorded |
| Phase 2 | NCT00328874 Comparator | May 2006 → Feb 2007 | progressive supranuclear palsy | German Parkinson Study Group (GPS) | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT07476443 Comparator | Apr 2026 → May 2027 expected | cisplatin toxicity | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT01126697 Comparator | Feb 2010 → Dec 2017 | Becker muscular dystrophy, Duchenne muscular dystrophy, limb-girdle muscular dystrophy | Cooperative International Neuromuscular Research Group | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT06515184 Comparator | Sep 2024 → Dec 2027 expected | mitochondrial respiratory chain complex deficiency, persian gulf syndrome | University of California, San Diego | Recruiting | No outcome recorded |
| Phase 3 | NCT04216186 Comparator | Nov 2018 → Dec 2030 expected | attention deficit-hyperactivity disorder | Tanta University | Recruiting | No outcome recorded |
| Phase 3 | NCT00608881 Comparator | Mar 2008 → Nov 2014 | Huntington disease | Massachusetts General Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT00432744 Comparator | Jan 2007 → May 2013 | mitochondrial disease | University of Florida | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05942027 Comparator | Jul 2023 → Jul 2026 overdue | chronic kidney disease | Tanta University | Recruiting | No outcome recorded |
| Phase 4 | NCT01026311 Comparator | Nov 2009 → Mar 2011 | statin toxicity | Richard Deichmann, MD | Completed | No outcome recorded |
| Phase not applicable7 trials | ||||||
| — | NCT06597682 Background | Mar 2025 → Jul 2027 expected | long COVID-19 | Huashan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07455890 Background | Jul 2024 → Jan 2026 | male infertility | Mst.Sumyara Khatun | Completed | No outcome recorded |
| — | NCT06576245 Background | Sep 2023 → Feb 2024 | dry eye syndrome | University of Seville | Completed | No outcome recorded |
| — | NCT03961087 Comparator | May 2019 → Jan 2020 | hepatic encephalopathy, intellectual disability | Zagazig University | Unknown | No outcome recorded |
| — | NCT03213769 Comparator | Jul 2017 → Jul 2018 | aphthous stomatitis | Cairo University | Unknown | No outcome recorded |
| — | NCT01140308 Comparator | Sep 2009 → Sep 2013 | statin toxicity | Hartford Hospital | Unknown | No outcome recorded |
| — | NCT00893724 Comparator | Jun 2009 → Aug 2011 | diabetic macular edema, wet macular degeneration | Mid-Atlantic Retina Consultations, Inc. | Unknown | No outcome recorded |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 101 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Coenzyme Q10 | “It consists of a preservative-free eye drop composed of 100 mg cross-linked hyaluronic acid, 100 mg coenzyme Q10, 500 mg vitamin E TPGS (D-alpha-tocopheryl polyethylene glycol...” NCT05429229 ↗75“food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg...” NCT06042738 ↗ “The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf...” NCT06515184 ↗ “Coenzyme Q10 (CoQ10) supplementation is the most popular therapy for statin myalgia among both physicians and patients despite limited and conflicting evidence of its efficacy.” PMID 25545331 ↗ Dec 2014 “Coenzyme Q10 (CoQ10)-an essential cofactor for energy production with major antioxidant properties-is commonly used to support spermatogenesis in idiopathic male infertility.” PMID 34070761 ↗ May 2021 “Coenzyme Q10 Impact on Ovarian Reserve Measures and the Intra-Cytoplasmic Sperm Injection (ICSI) Outcomes in Women with Poor Ovarian Response: A Randomized Controlled Study.” PMID 41800295 ↗ Mar 2026 “Patients will receive CoenzymeQ10 200mg three times per day for 7 days, until return to baseline neurologic status, or until death/discharge (whichever comes first).” NCT01319110 ↗ “Coenzyme Q10 (CoQ10) is a natural mitochondrial electron carrier and a powerful lipophilic antioxidant located in almost all cell membranes and plasma lipoproteins.” NCT05871086 ↗ “Coenzyme Q10 (CoQ10) or ubiquinone is one of a cell's most important electron carriers during oxidative phosphorylation and many other cellular processes.” PMID 38990401 ↗ Jul 2024 “Coenzyme Q10 (CoQ10) is an organic molecule can be found in both reduced (ubiquinol) and oxidised (ubiquinone) forms in mitochondria and cell membranes.” NCT05942027 ↗ “The study evaluates the effect of coenzyme q 10 on ovulation and subsequent pregnancy in women with polycystic ovarian syndrome.” NCT04302532 ↗ “Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Randomized Controlled Trial.” PMID 34819012 ↗ 2022 “Coenzyme Q10 (CoQ10) a lipid soluble coenzyme which is an important component of the inner membrane of mitochondria.” NCT05653895 ↗ “Coenzyme Q10 (CoQ10) or ubiquinone is a lipid-soluble vitamin-like antioxidant naturally found in the diet” NCT04091698 ↗ “Alpha Lipoic Acid Plus Coenzyme Q10 Versus Coenzyme Q10 Alone in Asthenozoospermia” NCT07455890 ↗ “daily 1200 mg of Co enzyme Q10 (CoQ10) and 1000 mg of Glutathione (GSH)” NCT06620523 ↗ “VisuXL gel® (Cross-linked Carboxymethyl Cellulose with Coenzyme Q10)” NCT06576245 ↗ “Coenzyme Q10 in Older Athletes Treated With Statin Medications” NCT01026311 ↗ “Coenzyme Q10 (Co enzyme Q10) is a fat-soluble molecule” NCT05293132 ↗ “Coenzyme Q10 in Pediatric Community-Acquired Pneumonia” NCT07317440 ↗ “CoenzymeQ10 100mg twice daily for 3 months” NCT07455890 ↗ “Coenzyme Q10 soft gelatin capsule 100mg” NCT03111433 ↗ “Quantification of CoQ10 (Coenzyme Q10)” NCT02218476 ↗ “1. CoEnzyme Q10: oral gel capsule bid” NCT01471652 ↗ “Dietary Supplement: Coenzyme Q 10” NCT07252518 ↗ “120 mg of Coenzyme Q10 (orally)” NCT00860743 ↗ “Drug: Co-Enzyme Q10” NCT05942027 ↗ “Coenzyme Q 10” NCT07476443 ↗ |
| Known as | API 31510 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00604890 ↗ |
| Known as | BPM31510 | “ubidecarenone injectable nanosuspension (BPM31510)” NCT03020602 ↗ |
| Known as | Coenzyme Q | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00117403 ↗ |
| Known as | CoQ | “The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).” NCT00117403 ↗ |
| Known as | COQ10 | “The study will also examine whether the food supplement Coenzyme Q10 (CoQ10) improves mitochondrial function and symptoms such as depressed mood, low energy, anxiety or...” NCT00327756 ↗32“Coenzyme Q10 (CoQ10) or ubiquinone is a lipid-soluble and vitamin-like compound, which acts as a pivotal cofactor in the mitochondrial respiratory chain in addition to its role...” NCT05984745 ↗ “Coenzyme Q(10) (CoQ(10)) is an electron acceptor bridging mitochondrial complexes I and II/III and a potent antioxidant that consistently partially recovers the function of...” PMID 17502459 ↗ May 2007 “This study explores whether coenzyme Q10 (CoQ10), a nutritional supplement with antioxidant and anti-inflammatory properties, can reduce pain after video-assisted thoracoscopic...” PMID 41025845 ↗ Sep 2025 “It has been shown that in an aged mouse model, administration of CoQ10 (ubiquinone) results in improved mitochondrial energy production, more healthy embryos and more live-born pups.” NCT06555575 ↗ “Coenzyme Q10 (CoQ10)-an essential cofactor for energy production with major antioxidant properties-is commonly used to support spermatogenesis in idiopathic male infertility.” PMID 34070761 ↗ May 2021 “Coenzyme Q10 (CoQ10), an antioxidant that supports mitochondrial function, has been shown in preclinical Parkinson disease (PD) models to reduce the loss of dopamine neurons” PMID 24664227 ↗ May 2014 “Coenzyme Q10 (CoQ10) is a natural mitochondrial electron carrier and a powerful lipophilic antioxidant located in almost all cell membranes and plasma lipoproteins.” NCT05871086 ↗ “Co Q10 or ubiquinone is an essential mitochondrial co-factor that has a critical role as a component of the electron transport chain and free radical scavenger.” NCT06620523 ↗ “This study investigated whether Coenzyme Q10 (CoQ10) could mitigate paclitaxel-induced adverse events and improve treatment tolerability.” PMID 42401951 ↗ Jul 2026 “CoenzymeQ10 will be given in 10 mg/kg daily up to 400 mg. Then a draw of CoQ10 troughs every three months will be performed.” NCT00432744 ↗ “Coenzyme Q10 (CoQ10) a lipid soluble coenzyme which is an important component of the inner membrane of mitochondria.” NCT05653895 ↗ “Coenzyme Q10 (CoQ10) or ubiquinone is a lipid-soluble vitamin-like antioxidant naturally found in the diet” NCT04091698 ↗ “Coenzyme Q10 (CoQ10) is an oil-soluble, vitamin-like substance primarily present in mitochondria.” NCT06856447 ↗ “Coenzyme Q10 (CoQ10) is an essential mitochondrial co-factor and free radical scavenger.” NCT01319110 ↗ “participants will receive ALA 500mg plus CoQ10 100mg twice daily for 3 months” NCT07455890 ↗ “Coenzyme Q10 (CoQ10) is the physiological electron recipient of complex I.” NCT00328874 ↗ “Patients will be treated with Coenzyme Q10 capsules (CoQ10) 200 mg/day.” NCT05942027 ↗ “montelukast and co-enzyme Q10 (CoQ10) in septic patients” PMID 40845766 ↗ Aug 2025 “oral coenzyme Q10 (CoQ10)” NCT01910766 ↗ |
| Known as | nanoQuinon | “to Assess the Safety, Tolerability, and Immediate Biological Effects of Coenzyme Q10 - nanoQuinon® in Progressive Supranuclear Palsy” NCT00328874 ↗ |
| Known as | Qred | “in vivo ubiquinol (reduced coenzyme Q10 [Qred]) supplementation” PMID 28684614 ↗ Jul 2017 |
| Known as | reduced coenzyme Q10 | “in vivo ubiquinol (reduced coenzyme Q10 [Qred]) supplementation” PMID 28684614 ↗ Jul 2017 |
| Known as | Ubidecarenone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03020602 ↗ |
| Known as | ubiquinol | “Coenzyme Q10 (ubiquinol) is an antioxidant that may play a significant role in the treatment of Attention Deficit Hyperactivity Disorder.” PMID 34819012 ↗ 20223“CoQ10 is available as ubiquinol (reduced form) or ubiquinone (oxidized form)” NCT06620523 ↗ “coenzyme Q10 (coQ10 or ubiquinol) versus topical corticosteroids” PMID 37480004 ↗ Jul 2023 “in vivo ubiquinol (reduced coenzyme Q10 [Qred]) supplementation” PMID 28684614 ↗ Jul 2017 |
| Known as | ubiquinone | “Coenzyme Q10 (CoQ10) or ubiquinone is a lipid-soluble and vitamin-like compound, which acts as a pivotal cofactor in the mitochondrial respiratory chain in addition to its role...” NCT05984745 ↗8“The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf...” NCT06515184 ↗ “Co Q10 or ubiquinone is an essential mitochondrial co-factor that has a critical role as a component of the electron transport chain and free radical scavenger.” NCT06620523 ↗ “Coenzyme Q10 (CoQ10) or ubiquinone is one of a cell's most important electron carriers during oxidative phosphorylation and many other cellular processes.” PMID 38990401 ↗ Jul 2024 “Coenzyme Q10 (CoQ10) or ubiquinone is a lipid-soluble vitamin-like antioxidant naturally found in the diet” NCT04091698 ↗ |
| Modality | Other / unclassified | “nutritional supplement Coenzyme Q10” NCT00033189 ↗ |
| Route | Oral | “antioxidant and mitochondrial cofactor, given in capsules three times daily” NCT00243932 ↗ |